This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rezazadeh, S. Articles by Fedida, D. Search for Related Content PubMed PubMed Citation Articles by Rezazadeh, S. Articles by Fedida, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB POTASSIUM Social Bookmarking                   What's this?

Rb+ Flux through hERG Channels Affects the Potency of Channel Blocking Drugs: Correlation with Data Obtained Using a High-Throughput Rb+ Efflux Assay

Department of Physiology, University of British Columbia, Vancouver, BC, Canada

J. Christian Hesketh

Cardiome Pharma Corp., Vancouver, BC, Canada

David Fedida

Department of Physiology, University of British Columbia, Vancouver, BC, Canada; Cardiome Pharma Corp., Vancouver, BC, Canada

The nonradioactive Rb⁺ efflux assay has become a reliable and efficient high-throughput hERG screening method, but it is limited by its low sensitivity for potent hERG blockers. Using the patch clamp technique, the authors found that the low sensitivity is due in part to the use of Rb⁺ as the permeating cation in the assay. The affinities of the drugs measured by patch clamp technique in the presence of Rb⁺ were 3- to 10-fold lower than when measured by the same method in the presence of K⁺ ions. The apparent affinity of the drugs decreased even further when monitored bytheRb⁺ efflux assay. It was also observed that Rb⁺ had minimal effects on the activation properties of channels while there was a significant change in the half-inactivation potential. This voltage shift reduces hERG channel inactivation at efflux assay potentials, and will reduce the affinity of hERG-blocking drugs that bind to inactivated states of the channel. In combination with the effects of elevated extracellular ion concentrations, it is likely that Rb⁺ modulation of hERG channel inactivation is largely responsible for the reduced drug potencies observed in the Rb⁺ efflux assay.

Key Words: hERG • Rb+ efflux assay • rubidium • Q-T interval • patch clamp

Journal of Biomolecular Screening, Vol. 9, No. 7, 588-597 (2004)
DOI: 10.1177/1087057104264798


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?